PTPN11 and Insulin resistance: Consistent with a rather global role of SHP2 in promoting insulin resistance, recent studies have taken advantage of the last generation of SHP2 inhibitors to document that pharmacological inhibition of SHP2 alleviates insulin resistance in obese/diabetic mice.